NCMM Associate Investigators and Young Associate Investigators

NCMM aims to continue to develop its scientific and technological capabilities by establishing strong collaborative links with key scientists and research groups across Norway, thus facilitating translational networking.

The Associate Investigator category is meant for outstanding scientists who are currently based in Norway, whose expertise is compatible with the NCMM research areas and who are interested in collaborating with NCMM. Associate Investigators are expected to contribute with their expertise in molecular and translational medicine, and be active in mentoring activities towards newly recruited NCMM Group Leaders and Young Associate Investigators.

NCMM has also initiated a Young Associate Investigator program for young talented researchers that are recruited as group leaders at another institution. Young Associate Investigators are identified by one of two routes: either by direct application to NCMM in open calls, or where universities and other research institutions that wish to recruit young, talented group leaders and where the conditions are similar to those offered to NCMM Group Leaders, can offer an affiliation to NCMM during the call. In the latter case NCMM must be contacted beforehand and will assist in the recruitment process of the NCMM Young Associate Investigator.

Both Associate Investigators and Young Associate Investigators continue to work at their host institutions but are credited an affiliation to NCMM and the Nordic EMBL Partnership.

NCMM has had twelve Associate Investigators in the first five-year period. Based on applications, seven Associate Investigators were re-appointed in 2015. In addition, one NCMM group leader was appointed Associate Investigator in 2014 when he rotated out of the Centre. Furthermore, two investigators at the University of Tromsø (UiT) were appointed NCMM Young Associate Investigators in 2014 in a joint recruitment process between UiT/ University Hospital of North Norway and NCMM.

Following an open call in spring 2015, applications for the status as Associate Investigators and Young Associate Investigators were evaluated by a Selection Committee, taking into account scientific excellence, translational merit, compatibility with the NCMM mission and added value for NCMM. The Committee found that the call was highly competitive with excellent applications. Consequently, in autumn 2015, the NCMM Board appointed five new Associate Investigators and seven new Young Associate Investigators. A third call, advertised in June 2017, saw a further six Associate and five Young Associate Investigators appointed after evaluation by a Selection Committee in November 2017. 

Altogether, the NCMM Associate Investigator and Young Associate Investigator network now consists of 31 excellent investigators:​​​​​​

NCMM Associate Investigators:

  • Professor Lars Akslen, Centre for Cancer Biomarkers (CCBIO), University of Bergen and Haukeland University Hospital (re-appointed 2015)
  • Professor Ole A. Andreassen, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo (re-appointed 2015)
  • Professor John-Bjarne Hansen, KG Jebsen – Thrombosis Research and Expertise Centre (TREC), Department of Clinical Medicine, UiT, The Arctic University of Norway and University Hospital of North Norway (appointed 2015)
  • Professor Bjørn Tore Gjertsen, Department of Clinical Science, University of Bergen and Haukland University Hospital (newly appointed 2017)
  • Professor Eivind Hovig, Department of Tumor Biology, Institute of Cancer Research, Oslo University Hospital and Institute of Informatics, University of Oslo (Newly appointed 2017)
  • Professor Arne Klungland, Department of Microbiology, Division of Diagnostics and Intervention, Institute of Clinical Medicine, Oslo University Hospital and Institute for Basic Medical Sciences, University of Oslo (appointed 2015)
  • Professor Dirk Linke, Section for Genetics and Evolutionary Biology, University of Oslo (newly appointed 2017)
  • Professor Per E. Lønning, Section of Medicine, University of Bergen and Department of Oncology, Haukeland University Hospital (re-appointed 2015)
  • Professor Karl-Johan Malmberg, Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital and Institute for Clinical Medicine, University of Oslo (appointed 2015)
  • Professor Erlend Nagelhus, Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo and Department of Neurology, Oslo University Hospital (appointed 2014)
  • Professor Hilde Loge Nilsen, Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital (newly appointed 2017)
  • Professor Ragnhild Lothe, Department of Cancer Prevention at Oslo University Hospital and Department of Molecular Biosciences at the University of Oslo (newly appointed 2018)
  • Professor Pål R. Njølstad, KG Jebsen Centre for Diabetes Research, University of Bergen and Department of Pediatrics, Haukeland University Hospital (re-appointed 2015)
  • Professor Johanna Olweus, KG Jebsen Center for Cancer Immunotherapy, Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital and University of Oslo (appointed 2015)
  • Professor Anne Simonsen, Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo (appointed 2015)
  • Associate Professor Rolf Skotheim, Department of Molecular Oncology, Institute of Cancer Research, Oslo University Hospital and Institute of Informatics, University of Oslo (newly appointed 2017)
  • Professor Anders Sundan, Department of Cancer Research and Molecular Medicine, Norwegian University for Science and Technology (NTNU) (appointed 2015)
  • Associate Professor Emre Yaksi, Kavli Institute for Systems Neuroscience/Centre for Neural Computation, Norwegian University of Science and Technology (NTNU) (newly appointed 2017)

NCMM Young Associate Investigators

  • Dr. Sören Abel, Department of Pharmacy, University of Tromsø and Harvard Medical School (appointed 2014)
  • Dr. Thomas Arnesen, Department of Molecular Biology, University of Bergen and Department of Surgery, Haukeland University Hospital (appointed 2015)
  • Dr. Lorena Arranz, Department of Medical Biology, University of Tromsø and Department of Hematology, University Hospital of Northern Norway (UNN) (appointed 2014)
  • Associate Professor Simona Chera, Department of Clinical Science, University of Bergen (appointed 2015)
  • Professor Jorrit Enserink, Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital (newly appointed 2017)
  • Professor Trude H. Flo, Centre of Molecular Inflammation Research (CEMIR) and Dept. of Cancer Research and Molecular Medicine, Norwegian University for Science and Technology (NTNU) (appointed 2015)
  • Dr. Nils Halberg, Department of Biomedicine, University of Bergen (newly appointed 2017)
  • Associate Professor Richard K Kandasamy, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU) (newly appointed 2017)
  • Dr. Ida G Lunde, Institute for Experimental Medical Research, Oslo University Hospital (newly appointed 2017)
  • Associate Professor Reidar Lund, Section for Chemical Life Sciences - Biomolecules, Bio-inspired Materials and Bioanalytics, Department of Chemistry, University of Oslo (newly appointed 2017)
  • Dr. Espen Melum, Norwegian PSC Research Center, Department of Transplantation Medicine, Oslo University Hospital (appointed 2015)
  • Associate Professor Siver Mostue, Department of Circulation and Medical Imaging and Department of Laboratory Medicine, Norwegian University for Science and Technology (NTNU) (appointed 2015)
  • Dr. Hege Russnes, Department of Pathology and Department of Cancer Genetics, Institute of Cancer Research, Oslo University Hospital (appointed 2015)
  • Dr. Pia Abel zur Wiesch, Department of Pharmacy, University of Tromsø and Yale School of Public Health, US (appointed 2015)
Published Dec. 19, 2016 7:28 PM - Last modified Jan. 18, 2018 1:16 PM